Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screening.

Authors

Georgianne L. Arnold, Children's Hospital of Pittsburgh
Denise Salazar, Quest Diagnostics
Julie A. Neidich, Ambry Genetics
Pim Suwannarat, Kaiser-Permanente
Brett H. Graham, Baylor College of Medicine
Uta Lichter-Konecki, George Washington University
Annet M. Bosch, University of Amsterdam
Kristina Cusmano-Ozog, George Washington UniversityFollow
Greg Enns, Stanford University
Erica L. Wright, University of Colorado
Brendan C. Lanpher, George Washington University
Natalie N. Owen, Children's Hospital at Vanderbilt
Mark H. Lipson, Kaiser Permanente
Roberto Cerone, G. Gaslini Institute, Genoa, Italy
Paul Levy, Children's Hospital at Montefiore
Lee-Jun C. Wong, Baylor College of Medicine
Antal Dezsofi, Semmelweis University, Budapest, Hungary

Document Type

Journal Article

Publication Date

8-2012

Journal

Molecular Genetics and Metabolism

Volume

Volume 106, Issue 4

Inclusive Pages

439-441

Keywords

Carbon-Carbon Ligases--deficiency; Neonatal Screening--methods; Urea Cycle Disorders; Inborn--diagnosis

APA Citation

Arnold, G. L., Salazar, D., Neidich, J. A., Suwannarat, P., Graham, B. H., Lichter-Konecki, U., . . . Dezsofi, A. (2012). Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screening. Molecular Genetics and Metabolism, 106(4), 439-441.

Peer Reviewed

1